Novartis Ireland Marks Collaboration Agreement With Deciphex
From Novartis Ireland on Linked:
Novartis Ireland were delighted to recently mark its Collaboration Agreement with Deciphex, a Dublin-based digital pathology company, at a specially convened panel discussion on Artificial Intelligence (AI).
Minister of State for Digital, Dara Calleary TD, officiated at the discussion, ‘How Ireland can be the Centre of Artificial Intelligence (AI) for Europe’, with panelists from Novartis and Deciphex and representatives from IDA Ireland and patients’ representative group IPPOSI (Irish Platform for Patient Organisations, Science and Industry).
The collaboration is a global agreement between Novartis and Deciphex. Harnessing cutting-edge technology, it seeks to develop a suite of AI tools that will improve the efficiency and accuracy of preclinical studies and accelerate the painstaking work of drug discovery and development.
The event heard from panelists that government policies and State support, ongoing investment and a strong pipeline of tech talent from universities are key factors in creating a fertile eco-system where the AI sector in Ireland is flourishing.
A big thank you to Minister Dara Calleary for taking the time to join the discussion, as well as the other panelists for providing hugely beneficial insights and expertise on How Ireland can become an integral part for Artificial Intelligence in healthcare going forward. We are very proud of or AI team in Elm Park.
Deciphex IDA Ireland International Financial Services Enterprise Ireland Irish Platform for Patient Organisations, Science, and Industry Ciara O’Connell
NovartisDublin NovartisIrelandInspires
SOURCE: LinkedIn
